PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90

Reported: July 17, 2019 Initiated: June 14, 2019 #D-1463-2019

Product Description

Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90

Reason for Recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Details

Units Affected
14,955 bottles (1,345,950 tablets)
Distribution
US Nationwide One (1) US government account. No foreign accounts.
Location
Camarillo, CA

Frequently Asked Questions

What product was recalled?
Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90. Recalled by Golden State Medical Supply Inc.. Units affected: 14,955 bottles (1,345,950 tablets).
Why was this product recalled?
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 17, 2019. Severity: Moderate. Recall number: D-1463-2019.